Cineplex Inc. (CGX)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 12.92 |
|---|---|
| 52-week range | 9.15 – 13.38 |
| Return, 1 month / 3 months | −0.5% / +7.0% |
| Return, 1 year / 3 years | +2.8% / +57.6% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 31.9% |
| Worst drawdown (1 year) | -26.9% |
| Average daily value traded | 4.88M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cineplex Inc. is a Canadian entertainment company based in Toronto that operates movie theatres across the country, showing films to the general public in its cinema locations. Beyond film exhibition, it runs a loyalty programme tied to entertainment and dining, offers digital movie rentals, and provides cinema advertising services to brands. The company also operates entertainment and dining venues that combine food, games and social activities, serving guests looking for leisure experiences outside the traditional cinema.
On this site Cineplex Inc. appears as a stock on the Toronto Stock Exchange (Canada), code CGX, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cineplex Inc. (CGX) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 12.92 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 136 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.8% and over the last three months it rose 7.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.6% | ||
| From 52-week high | -1.7% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.0% | ||
| 6-month return | 12.3% | ||
| 12-month return, skipping the last month | 3.3% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.9% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 4.88M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −0.5% |
| 3 months | +7.0% |
| 6 months | +12.3% |
| 1 year | +2.8% |
| 3 years | +57.6% |
| 5 years | −4.2% |
Signals
| 50-day / 200-day average | 12.50 / 11.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jan 2020 | CAD 0.1500 |
| 30 Dec 2019 | CAD 0.1500 |
| 28 Nov 2019 | CAD 0.1500 |
| 30 Oct 2019 | CAD 0.1500 |
| 27 Sep 2019 | CAD 0.1500 |
| 29 Aug 2019 | CAD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.